A case of CDllb-, CD14-and CD36-positive B-cell lymphoma terminating in acute monoblastic leukemia is presented. The patient was initially suspected as having angiotrophic lymphoma due to proliferation of lymphoma cells within the sinusoid of the liver and clinical signs. Following chemotherapy, the lymphomacells were converted into CDllb-and CD36-positive monoblasts. Lineage switching of B-cell lymphoma to acute monoblastic leukemia may have occurred in this case. (Internal Medicine 34: 36-38, 1995) 
Introduction
Biphenotypic leukemia is composedof different types of leukemia based on immunophenotypes (1, 2) . In lymphoma, however, the biphenotypes have not been well examined. We report here a case with CDlib-, CD14-, and CD36-positive lymphomaterminating in acute monoblastic leukemia.
Case Report
The details of this case were reported in part previously (3) . Briefly, the patient, a 52-year-old male, was hospitalized with dyspnea in December 1991. Physical examination revealed marked hepatosplenomegaly, and a chest X-ray demonstrated bilateral fine nodular infiltrates. Computerized tomography of the abdomen showed no lymphadenopathy in the para-aortic region. Laboratory evaluation revealed mild anemia and high titers of alkaline phosphatase and lactate dehydrogenase. Bone marrow aspiration and biopsy showed no atypical cells. One month later, his consciousness level deteriorated. No atypical cells were detected in the cerebrospinal fluid. A needle biopsy of the liver demonstrated proliferation of large atypical cells within the sinusoid. A small number of extremely large atypical cells with convoluted nuclei, prominent nucleoli and basophilic cytoplasm appeared in the peripheral blood (Fig. 1 ) . These cells showed neither peroxidase activity nor butyrate-esterase activity. The atypical cells were enriched by removal of adherent cells in the mononuclearcells separated from the peripheral blood, and were analyzed using flow cytometry. As shown in Table 1 , the cells were suggested to coexpress B-cell antigens and myelomonocytic antigens. In addition, they weakly expressed CD5. The karyotype of the mononuclear cells was 46, XY. The patient was suspected to have B -cell-type angiotrophic lymphomabecause of proliferation of the lymphoma cells within the sinusoid of the liver. The lymphoma cells had possibly infiltrated into the spleen, brain, and lungs. Following CHOPtherapy and ProMACE-CytaBOMtherapy, the abnormal physical and laboratory findings disappeared. After being discharged in June 1992, the patient received cyclic maintenance therapy in our outpatient clinic. In February 1993, he was hospitalized again due to the reappearance of pulmonary fine nodular infiltrates and hepatosplenomegaly. He received 2 cycles of ProMACECytaBOMtherapy. In May 1993, a large number of blast-like cells appeared in the peripheral blood and bone marrow. The cells were monoblast-like with peroxidase activity and intense butyrate-esterase activity ( Fig. 1) . They expressed CDlib, CD13, CD15 and CD36 (Table 1) , and the karyotype of the blasts was 46, XY. The patient was diagnosed as having acute monoblastic leukemia (AMoL, M5a), and died in June 1993 despite intensive induction therapy. No autopsy was performed.
Discussion
In mice, the relationship between B-cell and myeloid differentiation has been well studied. Transformed Ly-1+ (CD5+) Bcell precursors are capable of differentiating into macrophages (4, 5). Normal Ly-1+ B-cell precursors are also converted into macrophages in long-term bone marrow culture (6). In humans, one pre-B-cell line, RS4: 1 1, the CD5 phenotype of which has not been reported, was shown to be chemically induced to differentiate into monocytes/macrophages (7). These reports indicate that differentiation of B-cells and of monocytes/ macrophages may be closely related. In the present case, the lymphomacells coexpressed B-cell antigens and myelomonocytic antigens. Following chemotherapy, the cells were converted into monoblasts. Acute monoblastic leukemia in the present case was not thought to be related to the therapy; the disease appeared after only a short duration of therapy and CDlib and CD36antigens were expressed in the lymphoma cells which appeared initially and in the monoblasts which appeared later, although occasional expression of CD1 lb in Tlymphoma cells has been reported previously (8). However, molecular analyses such as for rearrangement of immunoglobulin heavy chain and point mutation of the ras oncogene were not examined in either lymphomacells or leukemic cells. Karyotypes of both of these cell types were normal. It is not clear whether the clone ofB-cell lymphomawas identical to that ofAMoL. In addition, etoposide, with which our patient was treated, is knownto induce secondary myeloid leukemia for a short time (9, 10). Therefore, the possibility of having developed secondary AMoLin the present case was not completely excluded. Recently, bipotential precursors ofB -cells and macrophages in murine fetal liver have been reported (ll). The cells coexpressing B220 and Mac-1 produce B-cell colonies, macrophage colonies, and the mixed colonies. These observations Internal Medicine Vol. 34, No. 1 (January 1995) indicate that the cells coexpressing B220and Mac-1 are bipotential precursors of B-cells and macrophages. The lymphoma cells in the present case maycorrespond to fetal liver cells since they expressed CD1lb (a-chain of Mac-1) and were converted into monobldsts. Since normal humanprecursor cells simultaneously expressing B -cell antigens and myelomonocytic antigens has not been reported, the lymphoma cells in the present case might have aberrantly expressed the myelomonocytic antigens. A number of cases with lymphoma coexpressing B-cell antigens and myelomonocytic antigens are necessary for analysis of clonality and ability to undergo monocytic differentiation.
